Uni-Bio Science Group Ltd
Develops biopharma therapies for endocrinology, ophthalmology, and dermatology needs.
Overview
Corporate Details
- ISIN(s):
- KYG9198H1406
- LEI:
- Country:
- Hong Kong
- Address:
- N/A
- Website:
- https://www.uni-bioscience.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Uni-Bio Science Group Ltd. is an integrated biopharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative therapies. The company's core research areas include endocrinology (such as diabetes and osteoporosis), ophthalmology (addressing conditions like dry eye and corneal injury), and dermatology, including medical aesthetics and wound healing. Uni-Bio Science operates across four integrated technology platforms: new drug research, clinical development, production and quality control, and commercial sales. Its pipeline features a differentiated portfolio of biological and chemical drugs, including proprietary treatments like Bogutai® and Uni-GLP-1, as well as cosmetic peptides and stem cell exosomes, aiming to address significant unmet medical needs and improve patient quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Uni-Bio Science Group Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Uni-Bio Science Group Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
